December 23, 2019 / 8:21 AM / a month ago

BRIEF-Sarepta Therapeutics Announces Partnership With Roche In Territories Outside The United States

Dec 23 (Reuters) - Sarepta Therapeutics Inc:

* SAREPTA THERAPEUTICS ANNOUNCES PARTNERSHIP WITH ROCHE IN TERRITORIES OUTSIDE THE UNITED STATES FOR ITS INVESTIGATIONAL MICRO-DYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY, SRP-9001

* SAREPTA THERAPEUTICS - TO RECEIVE UPFRONT PAYMENT OF $1.15 BILLION, COMPRISING $750 MILLION IN CASH AND $400 MILLION IN SAREPTA STOCK, PRICED AT $158.59 PER SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below